Kim P. Kamdar - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of Obalon Therapeutics Inc (OBLN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Obalon Therapeutics Inc (OBLN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Obalon Therapeutics Inc (OBLN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Kim P. Kamdar made 1 insider transaction in Evofem Biosciences Inc (EVFM) with a net sale of 10. Other recent insider transactions involving Evofem Biosciences Inc (EVFM) include a net sale of 104 shares made by Yan Zhang ,

In summary, during the past 3 months, insiders sold 0 shares of Evofem Biosciences Inc (EVFM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 114 shares of Evofem Biosciences Inc (EVFM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 114 shares.

Evofem Biosciences Inc (EVFM)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Bionano Genomics Inc (BNGO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Bionano Genomics Inc (BNGO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Bionano Genomics Inc (BNGO)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Ocera Therapeutics Inc (OCRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ocera Therapeutics Inc (OCRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ocera Therapeutics Inc (OCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Regado Biosciences Inc (RGDO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Regado Biosciences Inc (RGDO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Regado Biosciences Inc (RGDO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Kim P. Kamdar made no insider transaction in Syndax Pharmaceuticals Inc (SNDX). Other recent insider transactions involving Syndax Pharmaceuticals Inc (SNDX) include a net sale of 83,000 shares made by William Meury , a net sale of 52,855 shares made by Briggs Morrison , and a net purchase of 1,250 shares made by Keith A. Goldan .

In summary, during the past 3 months, insiders sold 0 shares of Syndax Pharmaceuticals Inc (SNDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 135,855 shares of Syndax Pharmaceuticals Inc (SNDX) were sold and 1,250 shares were bought by its insiders, resulting in a net sale of 134,605 shares.

Syndax Pharmaceuticals Inc (SNDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Kim P. Kamdar made no insider transaction in Glaukos Corp (GKOS). Other recent insider transactions involving Glaukos Corp (GKOS) include a net sale of 312,057 shares made by Joseph E Gilliam , a net sale of 6,762 shares made by Alex R. Thurman , and a net sale of 400,000 shares made by Thomas William Burns .

In summary, during the past 3 months, insiders sold 17,603 shares of Glaukos Corp (GKOS) in total and bought 0 shares, with a net sale of 17,603 shares. During the past 18 months, 834,726 shares of Glaukos Corp (GKOS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 834,726 shares.

Glaukos Corp (GKOS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Kim P. Kamdar made no insider transaction in aTyr Pharma Inc (ATYR). Other recent insider transactions involving aTyr Pharma Inc (ATYR) include a net purchase of 65,000 shares made by Sanjay Shukla , a net purchase of 3,410 shares made by Jill Marie Broadfoot , and a net purchase of 100,000 shares made by Paul Schimmel .

In summary, during the past 3 months, insiders sold 0 shares of aTyr Pharma Inc (ATYR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,590 shares of aTyr Pharma Inc (ATYR) were sold and 225,000 shares were bought by its insiders, resulting in a net purchase of 223,410 shares.

aTyr Pharma Inc (ATYR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Kim P. Kamdar made no insider transaction in Marinus Pharmaceuticals Inc (MRNS). Other recent insider transactions involving Marinus Pharmaceuticals Inc (MRNS) include a net sale of 18,588 shares made by Scott Braunstein , a net sale of 7,730 shares made by Joseph Hulihan , and a net sale of 7,461 shares made by Steven Pfanstiel .

In summary, during the past 3 months, insiders sold 0 shares of Marinus Pharmaceuticals Inc (MRNS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 45,796 shares of Marinus Pharmaceuticals Inc (MRNS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 45,796 shares.

Marinus Pharmaceuticals Inc (MRNS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Kim P. Kamdar made no insider transaction in Aldeyra Therapeutics Inc (ALDX). Other recent insider transactions involving Aldeyra Therapeutics Inc (ALDX) include a net sale of 2,074,234 shares made by Perceptive Life Sciences Master Fund Ltd , a net sale of 57,346 shares made by Stephen Machatha , and a net sale of 37,236 shares made by Bruce Greenberg .

In summary, during the past 3 months, insiders sold 0 shares of Aldeyra Therapeutics Inc (ALDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,034,319 shares of Aldeyra Therapeutics Inc (ALDX) were sold and 682,265 shares were bought by its insiders, resulting in a net sale of 2,352,054 shares.

Aldeyra Therapeutics Inc (ALDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Evoke Pharma Inc (EVOK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Evoke Pharma Inc (EVOK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Evoke Pharma Inc (EVOK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Kim P. Kamdar made no insider transaction in Esperion Therapeutics Inc (ESPR). Other recent insider transactions involving Esperion Therapeutics Inc (ESPR) include a net sale of 9,288 shares made by Eric Warren , a net sale of 26,997 shares made by Sheldon L. Koenig , and a net sale of 4,202 shares made by Joanne M. Foody .

In summary, during the past 3 months, insiders sold 18,230 shares of Esperion Therapeutics Inc (ESPR) in total and bought 0 shares, with a net sale of 18,230 shares. During the past 18 months, 43,732 shares of Esperion Therapeutics Inc (ESPR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 43,732 shares.

Esperion Therapeutics Inc (ESPR)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Celator Pharmaceuticals Inc (CPXX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Celator Pharmaceuticals Inc (CPXX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Celator Pharmaceuticals Inc (CPXX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Clovis Oncology Inc (CLVSQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Clovis Oncology Inc (CLVSQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Clovis Oncology Inc (CLVSQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Achillion Pharmaceuticals Inc (ACHN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Achillion Pharmaceuticals Inc (ACHN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Achillion Pharmaceuticals Inc (ACHN)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Zogenix Inc (ZGNX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Zogenix Inc (ZGNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Zogenix Inc (ZGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Orexigen Therapeutics Inc (OREXQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Orexigen Therapeutics Inc (OREXQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Orexigen Therapeutics Inc (OREXQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Kim P. Kamdar made no insider transaction in Reshape Lifesciences Inc (RSLS). Other recent insider transactions involving Reshape Lifesciences Inc (RSLS) include a net sale of 607 shares made by Thomas Stankovich ,

In summary, during the past 3 months, insiders sold 0 shares of Reshape Lifesciences Inc (RSLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 10 shares of Reshape Lifesciences Inc (RSLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 10 shares.

Reshape Lifesciences Inc (RSLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Kim P. Kamdar made no insider transaction in Sera Prognostics Inc (SERA). Other recent insider transactions involving Sera Prognostics Inc (SERA) include a net sale of 147,717 shares made by John J. Boniface , a net sale of 55,054 shares made by Austin Aerts , and a net sale of 181,466 shares made by Zhenya Lindgardt .

In summary, during the past 3 months, insiders sold 69,755 shares of Sera Prognostics Inc (SERA) in total and bought 0 shares, with a net sale of 69,755 shares. During the past 18 months, 468,459 shares of Sera Prognostics Inc (SERA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 468,459 shares.

Sera Prognostics Inc (SERA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Kim P. Kamdar made 1 insider transaction in Singular Genomics Systems Inc (OMIC) with a net sale of 631,648. Other recent insider transactions involving Singular Genomics Systems Inc (OMIC) include a net purchase of 117,418 shares made by Andrew Spaventa , a net purchase of 200,000 shares made by Eli N. Glezer , and a net purchase of 122,416 shares made by Kevin C Tang .

In summary, during the past 3 months, insiders sold 875 shares of Singular Genomics Systems Inc (OMIC) in total and bought 0 shares, with a net sale of 875 shares. During the past 18 months, 22,105 shares of Singular Genomics Systems Inc (OMIC) were sold and 133,032 shares were bought by its insiders, resulting in a net purchase of 110,927 shares.

Singular Genomics Systems Inc (OMIC)'s detailed insider trading history can be found in Insider Trading Tracker table.